Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Bone Biologics Corporation, a NASDAQ-listed developer of orthobiologic products for spine fusion, announced its participation in the upcoming H.C. Wainwright 28th Annual Global Investment Conference in New York. CEO Jeff Frelick will engage in investor meetings and present a virtual presentation focused on the company's regenerative medicine effort…